Galapagos NV (XBRU:GLPG)
€ 15.99 0 (0%) Market Cap: 1.73 Bil Enterprise Value: -1.60 Bil PE Ratio: 8.38 PB Ratio: 0.60 GF Score: 55/100

Galapagos NV to Acquire CellPoint BV and Abound Bio Inc M&A Call Transcript

Jun 22, 2022 / 12:00PM GMT
Release Date Price: €15.99
Sofie Van Gijsel
Galapagos NV - Head of IR

Welcome all to the Galapagos' webcast on the acquisition of CellPoint and the Abound Bio that we announced last night. Thank you all for joining. This recorded webcast is accessible via the Galapagos website homepage and will be available for downloads and replay later on today. We would like to remind everyone that we will be making forward-looking statements during today's webcast. These forward looking a include remarks concerning future developments of the pipeline and our company and possible changes in the industry and competitive environment. Because these forward-looking statements involve risks and uncertainties, Galapagos' actual results may differ materially from results expressed or implied in these statements.

Today's speakers will be Dr. Paulus Stoffels, CEO; joined by Toll Trimborn, CEO of CellPoint, and Dr. John Mellors, CEO of Abound Bio as well as by Bart Filius, CEO and President of Galapagos. Paul will reflect on the strategic rationality and highlights of the transaction. Then Toll and John will briefly introduce CellPoint and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot